Skip to main content
Equibles
VMD logo

VMD · Viemed Healthcare, Inc.

Track VMD — free

Use VMD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$9.08 +0.07 (+0.78%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$343.17M
Shares
38.09M

VMD metrics

88 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.08
Market cap
$343.17M

Price action

19 metrics
Price change (1W)
+2.9%
Price change (30D)
-4.6%
Price change (3M)
-8.9%
Price change (6M)
+3.4%
Price change (YTD)
+22.2%
Price change (1Y)
+33.1%
Trailing year
Price change (5Y)
+37.4%
52-week high
$12.33
52-week low
$6.26
Change from 52-week high
-26.4%
Change from 52-week low
+45.0%
Annualized volatility
39.8%
Beta
0.3
RSI (14D)
40.3
Price vs SMA 50
-14.2%
Price vs SMA 200
-0.6%
Avg volume (3M)
374,685
Relative volume
0.5
Average dollar volume
$3.91M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
38.09M

Valuation

12 metrics
P / E (TTM)
25.2
Trailing earnings · reciprocal yield 4.0%
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 88.8%
EV / EBITDA
6.5×
reciprocal yield 15.4%
EV / EBIT
14.9×
reciprocal yield 6.7%
P / sales
1.1×
reciprocal yield 87.9%
P / book
2.4
reciprocal yield 42.0%
FCF yield
8.5%
TTM · current market cap
Buyback yield
5.3%
P / FCF
11.7
reciprocal yield 8.5%
P / operating cash flow
5.6
reciprocal yield 17.7%
Earnings yield
4.2%

Historical valuation

8 metrics
P / E historical average (3Y)
28.7×
reciprocal yield 3.5%
P / E historical average (5Y)
31.4×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
5.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
57.5%
Operating margin
7.5%
Trailing 12 months
Net margin
4.8%
Gross profit (TTM)
$173.32M
Operating profit (TTM)
$22.77M
Net income (TTM)
$14.41M
Trailing 12 months
Diluted EPS (TTM)
$0.36
FCF margin
9.7%
Effective tax rate
29.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.87

Growth

11 metrics
Revenue growth YoY
+23.9%
Year over year
Net income growth YoY
-12.4%
Revenue (TTM)
$301.61M
Trailing 12 months
EPS growth YoY
-12.5%
Shares change YoY
+0.1%
Year over year · more shares
Revenue CAGR (3Y)
+24.9%
Revenue CAGR (5Y)
+15.5%
EPS CAGR (3Y)
+32.2%
EPS CAGR (5Y)
-13.9%
FCF CAGR (3Y)
+35.0%
FCF CAGR (5Y)
-11.6%

Quality

14 metrics
Return on equity
10.0%
Return on assets
7.1%
Debt / equity
0.0
Current ratio
1.1
EBITDA (TTM)
$52.43M
Free cash flow (TTM)
$29.24M
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
-0.1
Return on invested capital
11.5%
Trailing 12 months
Net cash
$3.59M
Latest balance sheet
Cash & equivalents
$10.68M
Total assets
$204.22M
Total debt
$7.09M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$60.78M
Capital expenditures (TTM)
$31.55M
R&D (TTM)
$2.46M
SG&A (TTM)
$136.06M
Stock compensation (TTM)
$8.96M
R&D / revenue
0.8%
Stock compensation / revenue
3.0%

Ownership (13F)

3 metrics
13F filers
165
13F filer change QoQ
+15
Institutional ownership
67.0%

Short interest

3 metrics
Short interest
2.1%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$347,167
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1729149 CUSIP 92663R105 13F (30d) 115 filings 114 filers Visit website Investor relations